MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs

Silvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, Daniela Di Marcantonio, Michael Hulse, Bac Viet Le, Huaqing Zhao, Katarzyna Piwocka, Italo Tempera, Stephen M. Sykes, Tomasz Skorski

Research output: Contribution to journalArticlepeer-review

18 Scopus citations
Original languageEnglish
Pages (from-to)1467-1472
Number of pages6
JournalBlood Advances
Volume1
Issue number19
DOIs
StatePublished - Aug 22 2017

Cite this